Diagnostics from Berlin-Brandenburg
Berlin-Brandenburg with its many high-performing companies and research facilities provides broad expertise in the development of innovative diagnostics.
The region’s dense research and clinical landscape, leading international diagnostics manufacturers and about 100 companies in the biotech sector cover the entire value-added chain for in vitro diagnostics.
The Center for Molecular Diagnostics and Bioanalysis (ZMDB) is the regional platform for technology transfer that connects basic research, technology development, clinical research and industrial application to promote the development and production of innovative diagnostics in Berlin-Brandenburg.
The ZMDB operates in close cooperation with the Fraunhofer Institute for Cell Therapy and Immunology - Branch Potsdam, Charité – Universitätsmedizin Berlin and the companies in the regional biotech industry.
The ZMDB was established to support the Joint Innovation Strategy of the states of Berlin and Brandenburg and is managed at Health Capital.